首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到7条相似文献,搜索用时 0 毫秒
1.
2.
目的 为制定一个可持续更新、基于循证医学和国际共识的髋、膝骨关节炎(OA)治疗指南,国际骨关节炎研究学会(OARSI)进行了一系列前期工作--对现有治疗指南进行严格评价及对近期研究依据进行系统性回顾.方法来自相关领域的16位专家(涵盖两大洲6个国家)组成该治疗指南研究小组,并邀请3位评价非英语文献的专家.在MEDLINE、EMBASE、SCI、CINAHL、AMED、Cochrane Library数据库,7个治疗指南网站以及Google上系统性检索OA治疗指南,4个由4人组成的评审小组对符合纳入及排除标准的治疗指南采用指南研究与评价评审表(AGREE)法进行评估,并对其适用范围、利益相关人员是否参与研究、严谨性、叙述是否清楚、可行性、编写的独立性以及总体质量进行百分制打分,对指南中论述及推荐的疗法加以总结.对每一种疗法的循证依据均经系统性回顾(2002年1月至2006年1月)进行更新.采用专门针对系统性回顾和随机对照研究评估的Oxman-Guyatt和Jadad方法,对各个循证依据分别在可能性、效能、需治疗数、相关风险、优势比、生活质量调整寿命年(QALY)费用等方面进行评分.结果 一共检索到1462个治疗指南,其中23个符合纳入/排除标准.基于专家意见,或循证依据,或两者皆有的得分,分别为28%、41%和51%(P=0.001).各方面评分从指南质量的18%到指南应用范围的67%不等.其中13个治疗指南已成为特定方面的治疗指南,包括5个用于初级护理、3个用于风湿病学、3个用于理疗、2个用于骨伤学,而有10个可普遍应用.同时,有14个治疗指南没有特别针对髋关节或膝关节,8个则专用于膝关节,只有1个专用于髋关节.在这些指南中涉及到51种不同的疗法,但只有20种被广泛推广应用.2002年1月至2006年发表的随机对照研究结果验证了一些疗法的有效性,如锻炼、有氧训练、水疗、非类固醇类消炎镇痛药(NSAID)等.近期不能确定其有效性的疗法有超声、推拿、冷热敷.这些疗法的不良反应也是各有不同.非选择性NSAID类药物的胃肠道风险及罗非昔布增加心肌梗死风险的证据均再次证实.其他药物潜在的相关不良反应,目前还尚无定论.结论 现有的23个OA治疗指南中有单纯源于专家观点的,也有源于循证研究或两者兼具的.51种疗法中有20种得到这些指南的广泛认同.上述表明现时仍存在着单纯源于专家建议的疗法;对现有治疗指南严格评价后发现,其总体质量不是很理想;广泛认可的疗法可能没有相关循证研究依据的支持.理想的OA治疗指南应将专家普遍的认可和循证研究依据的支持统一起来,并在其编写的独立性、应用的风险性及优越性等问题上有所侧重.通过这次对现有OA治疗指南的回顾,我们认识到现有的这些指南中存在一些不足.在今后OA治疗指南的修订中,有必要经常对一些新的循证依据进行系统性回顾.  相似文献   

3.
4.

Purpose

Studies comparing the outcome of spine surgery with that of large-joint replacement report equivocal findings. The patient-reported outcome measures (PROMs) used in such studies are typically generic and may not be sufficiently sensitive to the successes/failures of treatment. This study compared different indices of “success” in patients undergoing surgery for degenerative disorders of the lumbar spine, hip, or knee, using a validated, multidimensional, and joint-specific PROM.

Methods

Preoperatively and 12 months postoperatively, 4594 patients (3937 lumbar spine, 368 hip, 269 knee) undergoing first-time surgery completed a PROM that included the Core Outcome Measures Index (COMI) for the affected joint. The latter comprises a set of single items on pain, function, symptom-specific well-being, quality of life, and disability—all in relation to the specified joint problem. Other single-item ratings of treatment success were made 12 months postoperatively.

Results

In multiple regression analyses, controlling for confounders, the mean improvement in COMI at 12 months was greatest for the hip patients and lowest for those with degenerative spinal deformity (= the statistical reference group) (p < 0.05). Compared with spinal deformity, the odds of achieving “success” were: higher for hip (OR 4.6; 95% CI 2.5–8.5) and knee (OR 4.0; 95% CI 2.1–7.7) (no difference between spine subgroups) for “satisfaction with care”; higher for hip (OR 16.9; 95% CI 7.3–39.6), knee (OR 6.3; 95% CI 3.4–11.6), degenerative spondylolisthesis (OR 1.6; 95% CI 1.2–2.2), and herniated disc (OR 1.7; 95% CI 1.2–2.4) for “global treatment outcome”; and higher for hip (OR 13.8; 95% CI 8.8–21.6), knee (OR 5.3; 95% CI 3.6–7.8), degenerative spondylolisthesis (OR 1.6; 95% CI 1.3–2.1), and herniated disc (1.5; 95% CI 1.1–2.0) for “patient-acceptable symptom state”. Patient-rated complications were the greatest in degenerative spinal deformity (29%) and the lowest in hip (18%).

Conclusions

The current study is the largest of its kind and the first to use a common, but joint-specific instrument to report patient-reported outcomes after surgery for degenerative disorders of the spine, hip, or knee. The findings provide a sobering account of the significantly poorer outcomes after spine surgery compared with large-joint replacement. Further work is required to hone the indications and patient selection criteria for spine surgery. The data should be used to lobby research funding-bodies, governmental agencies, industry, and charitable foundations to invest more in spine research/registries, in the hope of ultimately improving spine outcomes.

Graphical abstract

These slides can be retrieved under Electronic Supplementary Material.
  相似文献   

5.
6.
7.
We reviewed 598 cemented Charnley and Hi-nek total hip arthroplasties at 7 years. Data were obtained from general practitioners, hospital medical notes, microfilm, and patient questionnaires. Outcome measures were revision rates, survival analysis, 12-item Oxford Hip Score, and satisfaction ratings. There were 471 Charnley (79%) and 127 Hi-nek (21%) total hip arthroplasties; 139 deaths (23%) occurred, and 5 (<1%) were lost to follow-up. Characteristics of the Charnley and Hi-nek patient groups were similar, with more information missing for Charnley cases. Revision rates were Charnley, 37 (8%), and Hi-nek, 6 (5%) (not significant). Survival analysis revealed no difference between the 2 groups (P = .23). The patients' median Oxford Hip Score was low/good (19), slightly worse for the Hi-nek group (not significant). Taking all evidence together, neither implant was outperforming the other at 7 years.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号